Literature DB >> 23161492

Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.

Hojjatollah N Charoudeh1, Grzegorz Terszowski, Karol Czaja, Asensio Gonzalez, Karin Schmitter, Martin Stern.   

Abstract

Patients carrying activating killer cell immunoglobulin-like receptor (KIR) genes are significantly protected from CMV-associated complications after solid organ or hematopoietic stem cell transplantation. Whether previous infection with CMV affects NK-cell function in healthy donors is unknown. We studied the KIR repertoire and alterations of KIR expression after in vitro exposure to CMV in 54 healthy donors. The expression of neither activating nor inhibitory KIRs was different at baseline between 23 seropositive and 31 seronegative donors. However, after co-culture of NK cells with CMV-infected fibroblast cells, expression of the inhibitory receptors KIR2DL1 and KIR2DL3 and the activating receptor KIR3DS1 significantly increased in CMV-seropositive donors. In CMV-seronegative donors, changes were subtle and restricted to the subset of NK cells expressing NK-cell group antigen 2C (NKG2C). Expansion of inhibitory KIRs occurred exclusively in donors carrying the cognate HLA class I ligands, whereas the presence of the putative ligand HLA-Bw4 was not necessary for the expansion of KIR3DS1-expressing NK cells. Our data show that previous infection with CMV does not alter the resting NK-cell receptor repertoire, but appears to modify how NK cells respond to re-exposure to CMV in vitro.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161492     DOI: 10.1002/eji.201242389

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

Review 1.  Harnessing adaptive natural killer cells in cancer immunotherapy.

Authors:  Lisa L Liu; Aline Pfefferle; Vincent Oei Yi Sheng; Andreas T Björklund; Vivien Béziat; Jodie P Goodridge; Karl-Johan Malmberg
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

2.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

3.  CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.

Authors:  Margaret L Green; Wendy M Leisenring; Hu Xie; Roland B Walter; Marco Mielcarek; Brenda M Sandmaier; Stanley R Riddell; Michael Boeckh
Journal:  Blood       Date:  2013-06-06       Impact factor: 22.113

4.  Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.

Authors:  Negin Farzamikia; Seyyedeh Mina Hejazian; Mehdi Haghi; Seyyed Sina Hejazian; Sepideh Zununi Vahed; Mohammadreza Ardalan
Journal:  Immunogenetics       Date:  2022-01-29       Impact factor: 2.846

5.  NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Authors:  Vivien Béziat; Lisa L Liu; Jenny-Ann Malmberg; Martin A Ivarsson; Ebba Sohlberg; Andreas T Björklund; Christelle Retière; Eva Sverremark-Ekström; James Traherne; Per Ljungman; Marie Schaffer; David A Price; John Trowsdale; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

6.  KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.

Authors:  A Gonzalez; K Schmitter; H H Hirsch; C Garzoni; C van Delden; K Boggian; N J Mueller; C Berger; J Villard; O Manuel; P Meylan; M Stern; C Hess
Journal:  Genes Immun       Date:  2014-07-10       Impact factor: 2.676

7.  2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells.

Authors:  S E Dunphy; K J Guinan; C Ní Chorcora; J Jayaraman; J A Traherne; J Trowsdale; D Pende; D Middleton; C M Gardiner
Journal:  Genes Immun       Date:  2015-05-07       Impact factor: 2.676

8.  Natural killer cell inhibitory receptor expression in humans and mice: a closer look.

Authors:  Michal Sternberg-Simon; Petter Brodin; Yishai Pickman; Björn Onfelt; Klas Kärre; Karl-Johan Malmberg; Petter Höglund; Ramit Mehr
Journal:  Front Immunol       Date:  2013-03-26       Impact factor: 7.561

9.  Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients.

Authors:  Vivien Béziat; Marwan Sleiman; Jodie P Goodridge; Mari Kaarbø; Lisa L Liu; Halvor Rollag; Hans-Gustaf Ljunggren; Jacques Zimmer; Karl-Johan Malmberg
Journal:  Front Immunol       Date:  2015-10-06       Impact factor: 7.561

10.  Virus encoded MHC-like decoys diversify the inhibitory KIR repertoire.

Authors:  Paola Carrillo-Bustamante; Can Keşmir; Rob J de Boer
Journal:  PLoS Comput Biol       Date:  2013-10-10       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.